[Uterine bleeding in hemorrhagic diathesis].
D000347:Afibrinogenemia / Q000150:complications; D000925:Anticoagulants / Q000009:adverse effects; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001779:Blood Coagulation Factors; D001791:Blood Platelet Disorders / Q000150:complications; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D006474:Hemorrhagic Disorders / Q000150:complications*; D006801:Humans; D014592:Uterine Hemorrhage / Q000188:drug therapy / Q000209:etiology*
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D005640:Follicle Stimulating Hormone
Uterine Blutungen bei hämorrhagischen Diathesen.